Recent News

• 06.06.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 06.06.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 06.06.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 05.29.2025 - Fulcrum Therapeutics to Present at Upcoming Medical Meetings
• 05.29.2025 - Fulcrum Therapeutics to Present at Upcoming Medical Meetings
• 05.29.2025 - Fulcrum Therapeutics to Present at Upcoming Medical Meetings
• 05.29.2025 - Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
• 05.29.2025 - Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
• 05.29.2025 - Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
• 05.09.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 05.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2025 - DEFR14A Revised definitive proxy soliciting materials
• 05.02.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors